Results for technologies (4)
Advanced filter
Pmel-1 TCR transduced cells (No. M7-2265)
This T-cell line, derived from the BWZ.36/CD8a thymoma of murine origin, was genetically engineered to express CD3 and a codon-optimized Pmel-1 T-cell receptor (TCR) through sequential retroviral transductions.
Bassan et al., Int J Cancer, 2019.
...
Read more
19345
B16F10.9 Cell Line (No. M7-2179)
Spontaneous metastatic spread of melanoma after surgery of the primary tumor. immunization against melanoma metastasis
Relevance: A model to study melanoma metastasis in mice.
Melanoma metastatic spread, immunization against melanoma metastasis
Relevant disease: melanoma
Porgador ...
Read more
19329
Optimized MAGE-A1 targeting TCR for T-cell Therapy (No. T4-1662)
TCR gene therapies show promise in cancer treatment but are hindered by the low natural avidity of TCRs against tumor-associated antigens. MAGE-A1 is a germline antigen expressed in many tumor types, making it a compelling target for TCR-based immunotherapy.
Cell therapy for MAGE-...
Read more
5572
Anti - gp100 T - cell Secreting Hybridoma [BUSA14 cell line] (No. M7-397)
Hybridoma cell line [clone BUSA14] which generates lacZ inducible CD8+ T -cells capable of recognizing both human and mouse gp100(25-33) melanoma antigens presented on dendritic and tumor cell lines.
Cafri G, Sharbi-Yunger A, Tzehoval E, Eisenbach L. Production of LacZ Inducible T...
Read more
Adi Sharbi-Yunger
Biology
Gal Cafri
Esther Tzehoval
Faculty of Biology
19317